Bellaire, TX

Bellaire, Texas 77401

2 studies enrolling now · 7 studies all time

What they study most

BRVO - Branch Retinal Vein Occlusion, Branch Retinal Vein Occlusion (BRVO), Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration, Neovascular Age-Related Macular Degeneration (NVAMD), Neovascular Age-related Macular Degeneration (NVAMD)

Studies at this site

• Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration — Recruiting now
• A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO — Recruiting now
• A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration — Running, not enrolling
• A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324 — Completed
• A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD) — Completed